Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin

Abstract

To gain better understanding of the molecular alterations responsible for the aggressive growth potential of epidermal growth factor receptor (EGFR)-positive breast cancers, we utilized an expression cloning strategy to seek gene products that mediate the EGF-independent growth of human breast cancer cells. A retroviral cDNA expression library was constructed from the EGFR-positive SUM-149PT cell line, and transduced into growth factor-dependent human mammary epithelial (HME) cells. Recipient cells were functionally selected for their ability to proliferate in serum-free, EGF-free medium. Library cDNAs were recovered from EGF-independent colonies by PCR amplification or by biological rescue. Clone H55a#1 contained a library insert encoding amphiregulin. This EGFR ligand was able to confer EGF independence when transduced into HME cells. SUM-149PT and H55a#1 cells overexpressed amphiregulin transcripts, and secreted moderate EGF-like activity in conditioned media, indicating a possible autocrine loop. EGFR membrane levels and constitutive phosphorylation were consistent with this hypothesis, as well as the sensitivity of the cells to an ErbB-specific kinase inhibitor. Expression of the WT1 Wilms' tumor suppressor gene, a transcriptional activator of amphiregulin, did not parallel amphiregulin transcript levels, suggesting that another factor regulates amphiregulin in SUM-149PT. Our data confirm the importance of amphiregulin in the etiology of breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 6
Figure 4
Figure 5

Similar content being viewed by others

References

  • Band V, Sager R . 1989 Proc. Natl. Acad. Sci. USA 86: 1249–1253

  • Band V, Zajchowski D, Swisshelm D, Trask D, Kulesa V, Cohen C, Connolly J, Sager R . 1990 Cancer Res. 50: 7351–7357

  • Barnard JA, Graves-Deal R, Pittelkow MR, DuBois R, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ . 1994 J. Biol. Chem. 269: 22817–22822

  • Battaglia F, Scambia G, Rossi S, Panici PB, Bellantone R, Polizzi G, Querzoli P, Negrini R, Iacobelli S, Crucitti F, Mancuso S . 1988 Eur. J. Cancer Clin. Oncol. 24: 1685–1690

  • Brown P, Fuqua S, Allred C . 2000 Endocrine Oncology: Contemporary Endocrinology. Ethier SP. (ed) Humana Press: Totowa, NJ pp. 49–68

  • Clarke RB, Howell A, Potten CS, Anderson E . 1997 Cancer Res. 57: 4987–4991

  • Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Collins VP, James CD, Liu L . 1994 Oncogene 9: 2313–2320

  • Ethier SP . 1995 J. Natl. Cancer Inst. 87: 964–973

  • Ethier SP, Chiodino C, Jones RF . 1990a Cancer Res. 50: 5351–5357

  • Ethier SP, Kudla A, Cundiff KC . 1987 J. Cell. Physiol. 132: 161–167

  • Ethier SP, Langton BC, Dilts CA . 1996 Mol. Carcinog. 15: 134–143

  • Ethier SP, Moorthy R, Dilts CA . 1991 Cell Growth Diff. 2: 593–602

  • Ethier SP, Summerfelt RM, Cundiff KC, Asch BB . 1990b Breast Cancer Res. Treat. 17: 221–230

  • Forozan F, Veldman R, Ammerman, CA, Parsa NZ, Kallioniemi A, Kallioniemi OP, Ethier SP . 1999 Br. J. Cancer 81: 1328–1334

  • Fry DW, Bridges AJ, Denny WA, Doherty A, Greis KD, Hicks JL, Hook KE, Keller PR, Leopold WR, Loo JA, McNamara DJ, Nelson JM, Sherwood V, Smaill JB, Trumpp-Kallmeyer S, Dobrusin EM . 1998 Proc. Natl. Acad. Sci. USA 95: 12022–12027

  • Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ . 1994 Science 265: 1093–1095

  • Harris AL, Nicholson S, Sainsbury JRC, Farndon J, Wright C . 1989 J. Steroid Biochem. 34: 123–131

  • Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ, Francke U, Reed JC, Kinoshita S, Nolan GP . 1998 Immunity 8: 461–471

  • Holdaway IM, Bowditch JV . 1983 Cancer 52: 479–485

  • Johnson GR, Kannan B, Shoyab M, Stromberg K . 1993 J. Biol. Chem. 268: 2924–2931

  • Kenney NJ, Smith GH, Rosenberg K, Cutler ML, Dickson RB . 1996 Cell Growth Diff. 7: 1769–1781

  • Kinoshita S, Su L, Amano M, Timmerman LA, Kaneshima H, Nolan GP . 1997 Immunity 6: 235–244

  • Kitamura T, Onishi M, Kinoshita S, Shibuya A, Miyajima A, Nolan GP . 1995 Proc. Natl. Acad. Sci. USA 92: 9146–9150

  • Kuukasjarvi T, Kononen J, Helin H, Holli K, Isola J . 1996 J. Clin. Oncol. 14: 2584–2589

  • Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W, Oliner JD, Haber DA . 1999 Cell 98: 663–673

  • LeJeune S, Leek R, Horak E, Plowman G, Greenall M, Harris AL . 1993 Cancer Res. 53: 3597–3602

  • Ma L, Gauville C, Berthois Y, Millot G, Johnson GR, Calvo F . 1999 Oncogene 18: 6513–6520

  • Martínez-Lacaci I, Saceda M, Plowman GD, Johnson GR, Normanno N, Salomon DS, Dickson RB . 1995 Endocrinology 136: 3983–3992

  • Nicholson S, Halcrow P, Farndon JR, Sainsbury JRC, Chambers P, Harris AL . 1989 Lancet 8631: 182–185

  • Nicholson S, Wright C, Sainsbury JR, Halcrow P, Kelly P, Angus B, Farndon JR, Harris AL . 1990 J. Steroid Biochem. Mol. Biol. 37: 811–814

  • Nicholson S, Sainsbury JRC, Needham GK, Chambers P, Farndon JR, Harris AL . 1988 Intl. J. Cancer 42: 36–41

  • Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJS . 1994 Proc. Natl. Acad. Sci. USA 91: 7727–7731

  • Normanno N, Kim N, Wen D, Smith K, Harris AL, Plowman G, Colletta G, Ciardiello F, Salomon DS . 1995 Breast Cancer Res. Treat. 35: 293–297

  • Osborne CK . 1985 Semin. Oncol. 12: 317–326

  • Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396

  • Pfeiffer JK, Topping RS, Shin NH, Telesnitsky A . 1999 J. Virol. 73: 8441–8447

  • Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, Shoyab M . 1990 Mol. Cell. Biol. 10: 1969–1981

  • Qi CF, Liscia DS, Normanno N, Merlo G, Johnson GR, Gullick WJ, Ciardiello F, Saeki T, Brandt R, Kim N, Kenney N, Salomon DS . 1994 Br. J. Cancer 69: 903–910

  • Ram TG, Ethier SP . 1996 Cell Growth Differ. 7: 551–561

  • Ram TG, Kokeny KE, Dilts CA, Ethier SP . 1995 J. Cell. Physiol. 163: 589–596

  • Rao GS, Murray S, Ethier SP . 2000 Intl. J. Radiation Oncol. Biol. Phys. 48: 1519–1528

  • Salomon DS, Bianco C, De Santis M, Martínez-Lacaci I, Wechselberger C, Ebert AD . 2000 Endocrine Oncology: Contemporary Endocrinology. Ethier SP. (ed. Humana Press: Totowa, NJ pp. 137–191

  • Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N, Kiessling M . 1994 Intl. J. Cancer 56: 72–77

  • Silberstein GB, Van Horn K, Strickland P, Roberts Jr CT, Daniel CW . 1997 Proc. Natl. Acad. Sci. USA 94: 8132–8137

  • Smaill JB, Rewcastle GW, Loo JA, Greis JD, Chan OH, Reyner EL, Lipka E, Showalter HDH, Fry DW, Sherwood V, Nelson JM, Denny WA . 2000 J. Med. Chem. 43: 1380–1397

  • Soule HD, Malony TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC . 1990 Cancer Res. 50: 6075–6086

  • Tannheimer SL, Rehemtulla A, Ethier SP . 2000 Breast Cancer Res. 2: 311–320

  • Toi M, Hamada Y, Nakamura T, Mukaida H, Suehiro S, Wada T, Toge T, Nimoto M, Hattori T . 1989 Intl. J. Cancer 43: 220–225

  • Visscher DW, Sarkar FH, Kasunic TC, Reddy KB . 1997 Breast Cancer Res. Treat. 45: 75–80

  • Whitehead I, Kirk H, Kay R . 1995 Mol. Cell. Biol. 15: 704–710

  • Woods Ignatoski KM, Ethier SP . 1999 Breast Cancer Res. Treat. 54: 173–182

  • Woods Ignatoski KM, Lapointe AJ, Radany EH, Ethier SP . 1999 Endocrinology 140: 3615–3622

  • zur Hausen H . 1999 Semin. Cancer Biol. 9: 405–411

Download references

Acknowledgements

We thank Dr Alice Telesnitsky for the pMLV Ψ-plasmid, Drs Stephan Stoll and JT Elder for the amphiregulin probe fragment, and Drs Wilber Leopold and David Fry for the CI-1033 EGFR kinase inhibitor. We also express our appreciation to Drs Michael Imperiale, Eric Fearon and the members of the Ethier laboratory for helpful discussions and Mrs Amy Pace for preparing the figures. This work was supported in part by Grant RO1 CA77416 from the NIH (to SP Ethier) and by a postdoctoral fellowship from the Pardee Foundation (to IM Berquin).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen P Ethier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berquin, I., Dziubinski, M., Nolan, G. et al. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin. Oncogene 20, 4019–4028 (2001). https://doi.org/10.1038/sj.onc.1204537

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204537

Keywords

This article is cited by

Search

Quick links